ibd
Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first projectÂ
January 22, 2025Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project
Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …
FDA approves AbbVie’s Skyrizi for UC treatment
June 20, 2024Medical Communications AbbVie, FDA, Gastrointestinal tract, UC, ibd
AbbVie has announced that the US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa) for the treatment of adult …
AbbVie and FutureGen announce license agreement for IBD therapy
June 14, 2024Research and Development FutureGen, Gastrointestinal tract, ibd, inflammatory bowel disease
AbbVie and FutureGen Biopharmaceutical have announced a license agreement for the development of FG-M701, a next-generation TL1A antibody for the …
Microba commences phase 1 clinical trial for IBD drug
June 28, 2023Medical Communications Biotherapeutic, Gastrointestinal tract, Microba, clinical trials, ibd
Australian precision microbiome company Microba has announced that the first participants in its phase 1 inflammatory bowel disease (IBD) clinical …
Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate
October 5, 2020Research and Development, Sales and Marketing Alivio, US, ibd, pharma
The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …
